4Q approvals
By BC Staff | Jan 4, 2010 | 8:00 AM GMT
4Q approvals
| Company | Approval |
| Amylin Pharmaceuticals Inc. (NASDAQ:AMLN)/ Eli Lilly and Co. (NYSE:LLY) | FDA approves Byetta exenatide to include monotherapy in Type II diabetes |
| AstraZeneca plc (LSE:AZN; NYSE:AZN) | FDA approves once-daily Seroquel XR quetiapine as an adjunct to antidepressants to treat major depressive disorder (MDD) |
| Baxter International Inc. (NYSE:BAX) | EC approves Celvapan H1N1 pandemic influenza vaccine |
| BioMimetic Therapeutics Inc. (NASDAQ:BMTI) | Canada approves Augment Bone Graft as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion
|
Read the full 880 word article
